Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020

The neuromodulation market is segmented on the basis of technology, application, and region. The global neuromodulation market is expected to grow at a CAGR of 11.2% from 2015 to 2020, to reach $6.20 Billion by 2020 from $3.65 Billion in 2015. Factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players, and expanded target applications and new indications are driving the growth of this market. Moreover, expansion in emerging economies is likely to create significant growth opportunities for players operating in the neuromodulation market. However, factors such as unfavorable reimbursement scenario and lack of trained professionals act as restraints hindering its market growth.

https://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.html

Some of the major players in the global neuromodulation market include Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Nevro Corporation (U.S.), Neurosigma, Inc. (U.S.), Neuropace, Inc. (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), and BioControl Medical (Israel).

https://www.marketsandmarkets.com/pdfdownload.asp?id=921

Scope of the Report:

This research report categorizes the neuromodulation market into the following segments and sub-segments:

Neuromodulation Market, by Technology

• Internal Neuromodulation
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Sacral Nerve Stimulation
  • Gastric Electrical Stimulation
• External Neuromodulation
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Respiratory Electrical Stimulation

Neuromodulation Market, by Application

• Spinal Cord Stimulation
  • Chronic Pain
  • Failed Back Surgery
  • Ischemia
• Deep Brain Stimulation
  • Parkinson's disease
  • Tremor
  • Depression
  • Others ( Alzheimer's disease, Dystonia, Tourette syndrome)
• Sacral Nerve Stimulation
  • Urine Incontinence
  • Fecal Incontinence
• Vagus Nerve Stimulation Market
  • Epilepsy

Others (Heart failure, Tinnitus)

• Gastric Electrical Stimulation
  • Gastroparesis
  • Obesity
• Transcranial Magnetic Stimulation
  • Depression
  • Migraine headaches
• Transcutaneous Electrical Nerve Stimulation
  • Treatment Resistant Depression
  • Others ( Stroke, Tinnitus)

Neuromodulation Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Rest of Europe (RoE)
• Asia
  • China
  • Japan
  • India
  • Rest of Asia (RoA)
• Rest of the World (RoW)

Foot and Ankle Devices Market by Product & Cause of Injury - 2020

Foot and ankle devices are used in various procedures like total ankle replacement, ankle fusions, fracture reduction, bunion removal, and diabetic foot amputation, among others. The products used in treating foot and ankle disorders include screws, wires and pins, plates, fusion nails, fixators, joint implants, soft tissue orthopedic implants, and bracing systems, among others. The foot & ankle joint implants market comprises reconstructive devices or implants used to replace failed joints, while soft tissue orthopedic devices help repair injuries of internal ligaments and tendons.

https://www.marketsandmarkets.com/Market-Reports/foot-ankle-devices-market-845.html

The global foot and ankle devices market is segmented on the basis of product, cause of injury, and region. By product, the market is categorized into orthopedic implants and devices, prostheses, and bracing and supporting devices. In 2015, the orthopedic implants and devices segment is estimated to account for the largest share of the foot and ankle market. This segment is expected to grow at the fastest rate during the forecast period.

On the basis of cause of inury, the market is divided into trauma, diabetes, neurological disorders, and others (osteoporosis, rheumatoid arthritis, osteoarthritis, hammertoe, and bunions). In 2015, the others segment is expected to account for the largest share of the market. However, the trauma segment is expected to grow at a faster rate during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=845

Growth in the number of sports injuries, an expected global rise in prevalence of diabetes, the rising prevalence of arthritis in Australia and the U.S., the regular entry of new products in the market, and rising geriatric population (resulting in growing incidence of bone) injuries are the major factors driving this market. On the other hand, the high cost of some foot and ankle devices and the excise tax on medical devices in the U.S. and are expected to restrain the growth of the market. The lack of trained professionals is a major challenge for the global market. However, the introduction of biologics to treat foot and ankle disorders and expansion & penetration opportunities in BRIC and South Africa are lucrative opportunities in the market.

Request Sample: https://www.marketsandmarkets.com/requestsample.asp?id=845

On the basis of regions, this market is categorized into North America, Europe, Asia-Pacific, and Rest of the World (RoW).

The foot and ankle devices market is expected to reach USD 5.41 Billion in 2020 from USD 3.82 Billion in 2015 at a CAGR of 7.2%. The market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is expected to grow at the fastest rate during the forecast period.

Some major players in the global market include Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Smith & Nephew plc (U.K.), Wright Medical Technology, Inc. (U.S.), Integra LifeSciences Holdings Corporation (U.S.), Tornier N.V. (Netherlands), Össur (Iceland), Acumed, LLC (U.S.), and Extremity Medical, LLC (U.S.).

Atherectomy Devices Market by Type, Application & End User - 2022

The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers.

https://www.marketsandmarkets.com/Market-Reports/atherectomy-devices-market-133112140.html

This report broadly segments the atherectomy devices market into product, application, end user, and region. On the basis of product, the market is categorized into directional, photo-ablative (laser), orbital, rotational atherectomy systems, and support devices. In 2017, the directional atherectomy devices segment is expected to account for the largest share of the market. It is also expected to register the highest CAGR during the forecast period. This can be attributed to the significant availability of credible clinical data to validate their clinical efficacy, rising availability of reimbursements for vascular treatment procedures across developed countries, high preference for minimally invasive procedures among medical professionals, clinical benefits offered, and ongoing technology advancements in the field of directional atherectomy.

Based on application, the atherectomy devices market is categorized into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular applications segment accounted for the largest share of the market and is expected to be the fastest growing segment during the forecast period. The large share of this segment is attributed to the significant availability of clinical evidence to support therapeutic efficacy of atherectomy in PVD treatment and rising availability of medical reimbursements for peripheral atherectomy procedures across developed countries.

Download PDF Brochure: https://www.marketsandmarkets.com/requestsample.asp?id=133112140

Based on end user, the atherectomy devices market is segmented into three categories, namely, hospitals and surgical centers, ambulatory care centers, and research laboratories & academic institutes. The hospitals and surgical centers segment accounted for the largest share of the market due to the increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment and growing availability of healthcare reimbursements across major countries.

This report covers the atherectomy devices market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America is expected to command the largest share of the market in 2017. Factors such as increasing availability of reimbursements for atherectomy systems, growing adoption of atherectomy systems among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials (that aim to evaluate the therapeutic efficacy of atherectomy systems in specific disease treatment) are driving the growth of the North American atherectomy devices market.

Factors such as stringent regulatory framework, significant adoption of alternative therapies, and dearth of well-trained surgeons to conduct atherectomy procedures are expected to restrain the growth of the atherectomy devices market during the forecast period.

The major players in the atherectomy devices market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), Cardiovascular Systems (US), Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Anesthesia Monitoring Devices Market by Product (Basic Anesthesia Monitors, Advanced Anesthesia Monitors, Integrated Anesthesia Workstations), End User (Hospital, Ambulatory Surgery Centers), and Geography - Global Forecast to 2020

Careful monitoring of the patient during and after surgery allows the anesthesiologist to identify problems at an early stage, when they can still be corrected. Basic monitoring must include ongoing evaluation of the major body systems. Proper monitoring of the patient can reduce the risks involved in anesthesia and surgery. Anesthesia monitors are available as a part of sophisticated multi-parameter patient monitors, as a component of a high-end anesthesia workstation, or as a standalone unit.

Technological changes as well as the growing use of anesthesia monitors in the freestanding surgery centers have contributed to the growth of the anesthesia monitor market. The global anesthesia monitoring devices market was valued at USD 820.9 Million in 2014 and is expected to reach USD 1,616.0 Million by 2020, at a CAGR of 12.0% from 2015 to 2020.

https://www.marketsandmarkets.com/Market-Reports/anesthesia-monitoring-devices-market-57663369.html

The global market is segmented based on product into basic parameter anesthesia monitors, advanced parameter anesthesia monitors, integrated anesthesia workstations, and others. Advanced parameter monitoring includes anesthesia gas monitoring, depth of anesthesia monitoring, standalone capnography monitors, and others, which includes MRI compatible anesthesia monitoring devices.

Having all monitors from the same manufacturer leads to economy in parts and provides better service. Modular equipment offer significant financial advantages despite the higher initial cost, as upgrading can be performed and modules can be swapped without taking the whole unit out of service. Some monitoring instruments are now being built into anesthesia machines. This usually results in economy of space and integration of machine, monitor information, and alarms.

Based on end user, the global anesthesia monitoring devices market is classified into hospital usage and ambulatory surgery centers. The report also provides a detailed analysis of anesthesia monitors for each region and country. Four major regions covered in the report are North America, Europe, Asia-Pacific, and rest of the world.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=57663369

The global anesthesia monitoring devices market is experiencing a robust growth owing to the rising clinical importance of monitored administration of anesthesia in care units. The number of surgical procedures using anesthesia are increasing by 6.5% every year. The mortality due to inappropriate dosage of anesthesia is about 0.003% globally. The market is also growing owing to the diversified applications and parameters that can be visualized using these devices.

Sample Request: https://www.marketsandmarkets.com/requestsample.asp?id=57663369

The report covers the competitive landscape of the global anesthesia monitoring devices market. It includes new product launches, recent developments, and mergers & acquisitions of the major players. The major players operating in this market are Mindray Medical International Limited (China), Drägerwerk AG & Co. KGaA (Germany), GE Healthcare (U.K.), Koninklijke Philips N.V. (The Netherlands), Schiller AG (Switzerland), Criticare Systems, Inc. (U.S.), HEYER Medical AG (Germany), Infinium Medical, Inc. (U.S.), Siare Engineering International Group S.r.l. (Italy), Nihon Kohden Corporation (Japan), Fukuda Denshi (Japan), General Meditech, Inc. (China), Skanray Healthcare Private Limited (India), and Medtronic (U.S.), among others.

Dental Bone Graft Substitutes Market worth 664.3 Million USD by 2021

The global dental bone graft substitutes market is expected to reach USD 664.3 Million by 2021, at a CAGR of 9.8% from 2016 to 2021. Increasing demand from customers for dental bone graft substitutes, growing inclination towards cosmetic dentistry, and rising industry standards are spurring the growth of the dental bone grafts substitutes market. However, unfavorable reimbursement scenarios in some countries is hampering the growth of the dental bone grafts substitutes market.

https://www.marketsandmarkets.com/Market-Reports/dental-bone-graft-substitutes-market-159678690.html

The global dental bone graft substitutes market is segmented on the basis of type, application, and region. The geographic analysis covers North America, Europe, Asia-Pacific, and Rest of the World (RoW). RoW includes Latin America, the Middle East, and Africa.

On the basis of type, the dental bone graft substitutes market has been segmented into synthetic bone graft, xenograft, allograft, and demineralized allograft. The shift from autografts to allografts and further usage of synthetic and tissue engineered bone grafts due to the technological advancements taking place in the medical sector are propelling the growth of the market.

The xenograft segment is estimated to account for the largest share of the global dental bone graft substitutes market in 2016. Benefits, such as easy availability, sterility, reduced morbidity, long shelf life, and reduced risks of disease transfer offered by synthetic grafts are leading towards their increased usage as dental bone graft substitutes.

Dental bone graft substitutes are mainly used in ridge augmentation, socket preservation, periodontal defect regeneration, implant bone regeneration, and sinus lift procedures. The socket preservation application segment is estimated to account for the largest share of the market in 2016.

Socket preservation is a procedure that is used to reduce bone loss from tooth socket in alveolar bone after tooth extraction. Increasing number of dental implant procedures and growing awareness among people about oral care are the factors driving growth of this segment of the dental bone graft substitutes market.

DOwnload PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=159678690

Bio-Oss is one of the leading products in the dental bone graft substitutes market. It is manufactured using organic components obtained from bovine bone, which is similar to human bone. It is porous and non-antigenic in nature. This product is easy to apply and has its application areas in extraction sockets, horizontal augmentation, peri-implant defects, periodontal regeneration, ridge augmentation, sinus floor elevation, and vertical augmentation. Geistlich Holding is engaged in the manufacturing and production of Bio-Oss.

The European region is estimated to account for the largest share of the dental bone graft substitutes market in 2016. As implant dentistry originated in the European region, the penetration rate of dental bone graft substitutes is very high in this region. The main factors driving the growth of the Europe market are the continuous increase in aging population, governmental expenditure on oral healthcare across the region, and the high reimbursement rate although limited to Germany, Sweden, and the Netherlands.

The dental bone graft substitutes market is a competitive market with a large number of companies operational in the market. The competitive landscape includes an in-depth market share analysis along with the key business strengths of the leading market players. Some of the leading players offering dental bone graft substitutes products are Geistlich Pharma AG (Switzerland), Zimmer Dental Inc. (U.S.), Dentsply Sirona (U.S.), LifeNet Health (U.S.), RTI Surgical, Inc. (U.S.), BioHorizons IPH, Inc. (U.S.), and ACE Surgical Supply Company, Inc. (U.S.).

Foot and Ankle Devices Market by Product & Cause of Injury - 2020

Foot and ankle devices are used in various procedures like total ankle replacement, ankle fusions, fracture reduction, bunion removal, and diabetic foot amputation, among others. The products used in treating foot and ankle disorders include screws, wires and pins, plates, fusion nails, fixators, joint implants, soft tissue orthopedic implants, and bracing systems, among others. The foot & ankle joint implants market comprises reconstructive devices or implants used to replace failed joints, while soft tissue orthopedic devices help repair injuries of internal ligaments and tendons.

https://www.marketsandmarkets.com/Market-Reports/foot-ankle-devices-market-845.html

The global foot and ankle devices market is segmented on the basis of product, cause of injury, and region. By product, the market is categorized into orthopedic implants and devices, prostheses, and bracing and supporting devices. In 2015, the orthopedic implants and devices segment is estimated to account for the largest share of the foot and ankle market. This segment is expected to grow at the fastest rate during the forecast period.

On the basis of cause of inury, the market is divided into trauma, diabetes, neurological disorders, and others (osteoporosis, rheumatoid arthritis, osteoarthritis, hammertoe, and bunions). In 2015, the others segment is expected to account for the largest share of the market. However, the trauma segment is expected to grow at a faster rate during the forecast period.

Growth in the number of sports injuries, an expected global rise in prevalence of diabetes, the rising prevalence of arthritis in Australia and the U.S., the regular entry of new products in the market, and rising geriatric population (resulting in growing incidence of bone) injuries are the major factors driving this market. On the other hand, the high cost of some foot and ankle devices and the excise tax on medical devices in the U.S. and are expected to restrain the growth of the market. The lack of trained professionals is a major challenge for the global market. However, the introduction of biologics to treat foot and ankle disorders and expansion & penetration opportunities in BRIC and South Africa are lucrative opportunities in the market.

Downloa PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=845

On the basis of regions, this market is categorized into North America, Europe, Asia-Pacific, and Rest of the World (RoW).

Note: The size of the bubble chart depicts market size (USD Billion) in 2015

The foot and ankle devices market is expected to reach USD 5.41 Billion in 2020 from USD 3.82 Billion in 2015 at a CAGR of 7.2%. The market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is expected to grow at the fastest rate during the forecast period.

Some major players in the global market include Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Smith & Nephew plc (U.K.), Wright Medical Technology, Inc. (U.S.), Integra LifeSciences Holdings Corporation (U.S.), Tornier N.V. (Netherlands), Össur (Iceland), Acumed, LLC (U.S.), and Extremity Medical, LLC (U.S.).

Product Launches and Strategic Acquisitions Are the Key Growth Strategies Adopted by Leading Market Players in the Global Atherectomy Devices Market

The global atherectomy devices market is projected to reach USD 1.45 billion by 2022 from 1.08 billion in 2017, at a CAGR of 6.1%. Some of the factors driving the growth of this market are the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers. 

http://www.marketsandmarkets.com/Market-Reports/atherectomy-devices-market-133112140.html

However, limited patient awareness related to disease diagnosis (resulting in delayed treatment for peripheral vascular diseases), stringent regulatory framework, dearth of well-trained surgeons to conduct atherectomy procedures, and significant adoption of alternative therapies are the key challenges faced by a majority of the atherectomy device manufacturers across the globe.

Analysis of the market developments between 2014 and 2017 (October) reveals that several growth strategies such as product launches, strategic acquisitions, mergers, market expansions, agreements, partnerships, and collaborations are adopted by the market players to strengthen their product portfolios and maintain a competitive position in the atherectomy devices market. Among these business strategies, product launches and strategic acquisitions were the most widely adopted growth strategies by players in the market.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=133112140

Medtronic (Ireland) holds the leading position in the market with its broad range of atherectomy products. The company has strong distribution networks across 160 countries across Asia Pacific, Eastern Europe, Latin America, the Middle East & Africa, Central Asia, Western Europe, South Asia, and North America. The company primarily focuses on product launches and strategic acquisitions to sustain its position in the atherectomy devices market. 

The company acquired Covidien (US) to expand its interventional product portfolio including atherectomy devices. In addition, the market has witnessed the launch of its HawkOne 6F directional atherectomy devices in 2015.

 Philips (Netherlands) is one of the prominent players in the atherectomy devices market. The company has a strong foothold in the market with a wide range of atherectomy devices. 

The company mainly focuses on strategic acquisitions to strengthen its minimally invasive product portfolio as well as to expand its customer base in the atherectomy devices market. 

For instance, in August 2017, the company acquired Spectranetics (US) to expand its image-guided therapy business group, which includes atherectomy devices. 

Powered Surgical Instruments Market by Product & Application - 2020

The global powered surgical instruments market is estimated to be worth around USD 1.7 Billion in 2014 and is expected to reach around USD 2.2 Billion to grow at a CAGR of 4.1% during the forecast period of 2015 to 2020. This market is mainly driven by increasing aging population, high prevalence of chronic disorders requiring surgical interventions, and high disposable income among consumers. Moreover, rapid technological innovation is also contributing to the growth of this market. However, market growth is restricted due to inadequate quality assurance, lack of proper sterilization practices for equipment, and high price competition among manufacturers.

For Full Report, Click here

The global powered surgical instruments market is divided on the basis of power source, product, and application. Based on type of power source, the market is mainly segmented into electric instruments, battery-powered instruments, and pneumatic instruments. The powered surgical instruments products market is divided into handpieces; power source and control; and accessories. The handpieces market is further segmented into drill systems, saw systems, reamer systems, staplers, shavers, wire/pin drivers, and others. Likewise, the power source and control market is segmented into batteries, electric consoles, and pneumatic regulators. The accessories market is sub-segmented into surgical accessories, electrical accessories, and other accessories.

The market, by application, is classified into orthopedic surgery, oral and maxillofacial surgery, ENT surgery, neurosurgery, plastic and reconstructive surgery, and cardiothoracic surgery. The market is further divided into four major regions— North America, Europe, Asia-Pacific, and Rest of the World (RoW). These regions are further analyzed at the country-level. The research report discusses key market drivers and restraints of, and the opportunities in, the global market and its submarkets.

Download PDF Brochure:  http://www.marketsandmarkets.com/pdfdownload.asp?id=239163256

In 2014, the electric instruments segment accounted for the largest share of the market. This can be attributed to the low prices of these instruments, and their applications in orthopedic surgery, oral surgery, ENT surgery, neurosurgery, plastic and reconstructive surgery, and cardiothoracic surgery. However, the battery-powered surgical instruments segment is expected to grow at the highest CAGR in the market during the forecast period.

North America represented the largest regional market in 2014, followed by Europe, Asia-Pacific, and RoW. North America and Europe are expected to witness lower growth rates in the coming years than the Asia-Pacific market. The Asia-Pacific region represents the fastest-growing market for powered surgical instruments equipment and accessories, primarily due to the increasing medical tourism, rising prevalence of chronic diseases that require surgical procedures, and increased accessibility to healthcare facilities in the region.

Major players in the powered surgical instruments market include B. Braun Melsungen AG (Germany), CONMED Corporation (U.S.), Johnson & Johnson (U.S.), Medtronic, Inc. (U.S.), Stryker Corporation (U.S.), Smith & Nephew (U.K.) and Zimmer Holdings (U.S.).

Professional Dental Care Market by Type (Toothbrush (Electric, Battery-powered), Toothpaste, Mouthwash, Denture Products, Dental Accessories (Whitening Products, Breath Freshener, Dental Floss, Dental Water Jet)) - Global Forecast to 2021

The professional dental care market is expected to witness significant growth in the coming years. Factors such as the growing number of small/private dental clinics, rising incidences of dental caries, increasing disposable income in emerging countries, rising awareness about dental hygiene, an economic gain for dental practitioners are the major factors driving the growth of the global market. The global market is projected to USD 961.0 Million by 2021 from USD 769.3 Million in 2016, at a CAGR of 4.5% from 2016 to 2021. However, the rising trend of group/large dental practices and reluctance by dental practitioners towards the dental dispensing practices are expected to restrain the growth of this market to certain extent.

For Full report, Please Click here 

This study includes the estimation of professional dental care market based on type-of-products and region. On the basis of product types, this market is segmented into toothpastes, toothbrushes, mouthwashes/rinses, dental accessories/ancillaries, denture products, and other professional dental care products. The toothpastes segment accounted for the largest share of the global market in 2015. The toothbrushes segment is expected to register fastest growth during the forecast period of 2016-2021. The significant growth of this segment is mainly attributed to the recent technological advancements in the electric toothbrushes.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=210346692

In 2015, Europe dominated the professional dental care market followed by North America, Asia-pacific, and Rest of the World. This is mainly due to the region’s aging population, governmental expenditure on oral healthcare across Europe, availability of huge amount of private dental practitioners in European countries, and growing awareness about dental hygiene. However, Asia-Pacific is expected to witness the fastest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the increasing number of geriatric population, growing number of dental diseases, growing dental expenditure, increasing number of dental hospitals and clinics, and growing dental tourism across APAC countries.

The global professional dental care market is characterized by the presence of a large number of players. Amidst intense market competition, major players are continuously focusing on achieving higher market shares through new product launches, expansions, and mergers and acquisitions in the market. The global market is fragmented in nature, with a large number of companies continuously trying to mark their presence. The market is led by Colgate-Palmolive Company (U.S.), The Procter & Gamble Company (U.S.), Unilever plc (U.K.), Johnson & Johnson (U.S.), Young Innovation, Inc. (U.S.), Ultradent Products, Inc. (U.S.), GC Corporation (Japan), GlaxoSmithKline plc (U.K.), Dr. Fresh, LLC (U.S.), 3M Company (U.S.), Koninklijke Philips N.V. (Netherlands), and Sunstar (Japan).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Latin America Medical Gases and Equipment Market worth 1.8 Billion USD by 2020

The report “Latin America Medical Gases & Equipment Market by Product (Oxygen, Medical Air, Nitrogen, Carbon Dioxide, Nitrous Oxide, Helium, Ethylene Oxide, Blood-gas Mixture, Cylinder, Hoses, Manifold, Regulator) End User (Hospital, Home Care) - Forecast to 2020”, the Latin America medical gases and equipment market is estimated to reach around USD 1.8 Billion by 2020 at a CAGR of 10.2% during the forecast period of 2015 to 2020.

Browse 99 market data tables and 32 figures spread through 146 pages and in-depth TOC on "Latin America Medical Gases & Equipment Market by Product (Oxygen, Medical Air, Nitrogen, Carbon Dioxide, Nitrous Oxide, Helium, Ethylene Oxide, Blood-gas Mixture, Cylinder, Hoses, Manifold, Regulator) End User (Hospital, Home Care) - Forecast to 2020"
http://www.marketsandmarkets.com/Market-Reports/latin-america-medical-gases-equipment-market-23844890.html
Early buyers will receive 10% customization on reports.

The Latin American medical gases and equipment market is growing at a high rate and further expected to experience considerable growth in the forecast period. Growth in this market is mainly attributed to the rising prevalence of lifestyle and respiratory diseases, rising geriatric population, high prevalence of smoking, rising pollution levels, and growing demand for home healthcare products. However, the low efficiency of healthcare systems in Latin America and the recent economic slowdown in the region are the major challenges in this market.

]

In this report, the Latin American medical gases and equipment market is segmented on the basis of products and end users. On the basis of products, the Latin American medical gases and equipment market is segmented into medical gases and medical gas equipment. The medical gas equipment segment is further divided into cylinders, vacuum systems, manifolds, regulators, cryogenic products, flowmeters, suction regulators, monitoring systems, hoses, and outlets. The medical gases segment is categorized into pure medical gases and medical gas mixtures. The pure medical gases segment is subdivided into oxygen, nitrous oxide, medical air, nitrogen, carbon dioxide, and helium. The medical gas mixtures segment is categorized into blood-gas mixtures, lung diffusion mixtures, nitrous oxide-oxygen mixtures, carbon dioxide-oxygen mixtures, laser-gas mixtures, aerobic gas mixtures, anaerobic gas mixtures, ethylene oxide mixtures, and helium-oxygen mixtures.

In 2014, the medical gas equipment segment accounted for the largest share of the Latin America medical gases and equipment market. The large share of this segment is mainly attributed to the rising demand for home healthcare devices and rising geriatric population.

DOwnload PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=23844890

On the basis of end users, the Latin American medical gases and equipment market is divided into hospitals, home healthcare, pharmaceutical & biotechnology companies, and academic & research institutions. Hospitals are the major end users of the Latin American medical gases and equipment market, owing to the financial capabilities of hospitals to purchase high-end instruments as well as the availability of trained professionals to operate these devices.

The Latin American medical gases and equipment market is broadly segmented into Brazil, Mexico, Argentina, Colombia, Chile, Peru, Venezuela, Ecuador, Uruguay, and the Rest of Latin America. Its highly developed healthcare insurance system and high healthcare expenditures are the major factors responsible for the large share of Brazil in the Latin American medical gases and equipment market. However, the Mexico is expected to grow at the highest CAGR, owing to increasing incidence of lifestyle diseases, favorable government efforts further improving healthcare infrastructure, increasing per capita incomes, and growing middle-class population.

Major players in the Latin American medical gases and equipment market include The Linde Group (Germany), Air Liquide (France), Praxair, Inc. (U.S.), Air Products and Chemicals, Inc. (U.S.), Atlas Copco AB (Sweden), and Taiyo Nippon Sanso (Matheson Tri-Gas) (Japan).

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Pain Management Devices Market worth 4.64 Billion USD by 2021

Pain management device are used to manage chronic and acute pain in patients suffering from various conditions, such as cancer, neurological disorders, and musculoskeletal disorders. These devices restore the ability of patients to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions.

http://www.marketsandmarkets.com/Market-Reports/pain-management-devices-market-91418163.html

The global pain management devices market is estimated to grow at a CAGR of 8.5% from 2016 to 2021 to reach USD 4.64 Billion by 2021. The growth in this market is primarily driven by factors such as the presence of a large patient population base and adverse effects associated to the use of pain medications.

Based on type, the pain management devices market is categorized into neurostimulation devices (transcutaneous electrical nerve stimulation (TENS) and spinal cord stimulation (SCS)), ablation devices (RF ablation and cryoablation), and analgesic infusion pumps (intrathecal and external infusion pumps). The neurostimulation devices segment is expected to account for the largest share of the market in 2016. This can majorly be attributed to the cost-effectiveness of neurostimulation devices, high efficacy of TENS and SCS devices in alleviating chronic pain, and availability of reimbursement for SCS therapy in developed countries.

On the basis of applications, the pain management devices market is segmented into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and other applications (pregnancy/labor and menstrual pain, sports injuries, post-operative pain, and trauma pain). The neuropathic pain segment is estimated to witness the highest growth during the forecast period, primarily due to the high prevalence of diseases resulting in neuropathic pain.

On the basis of mode of purchase, the market is categorized into over-the-counter and prescription-based pain management device. The prescription-based devices segment is estimated to command a larger share, majorly due to the longer market presence of these devices with established safety and efficacy profiles and their long-term cost effectiveness.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=91418163

In 2015, North America accounted for the largest share of the global pain management devices market, followed by Europe. However, the Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, due to the rising incidence of chronic diseases, increasing government support, and growing middle-class population and disposable income levels in this region.

Leading players in the pain management devices market are focusing on the strategies of new product launch and geographic expansion. These strategies help market players to strengthen their product portfolios, streamline their manufacturing capabilities, expand their distribution networks, and penetrate into high-growth markets.

Medtronic plc (Ireland), St. Jude Medical, Inc. (U.S.), and Boston Scientific Corporation (U.S.) were the top players in the pain management devices market in 2015.

Atherectomy Devices Market worth 1.45 Billion USD by 2022

The report "Atherectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) - Global Forecasts to 2022", The report studies the global atherectomy devices market over the forecast period of 2017 to 2022. The market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. Factors such as favorable reimbursement scenario for atherectomy procedures, increasing number of research activities in the field of atherectomy, and increasing healthcare expenditure are driving the growth of the market.

Browse 77 Market Data Tables and 47 Figures spread through 149 Pages and in-depth TOC on "Atherectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) - Global Forecasts to 2022"
http://www.marketsandmarkets.com/Market-Reports/atherectomy-devices-market-133112140.html
Early buyers will receive 10% customization on reports.

Based on product, the directional atherectomy devices segment is expected to witness the highest growth during the forecast period.

On the basis of product, the atherectomy devices market is categorized into directional, orbital, photo-ablative (laser), rotational atherectomy devices, and support devices. In 2017, the directional atherectomy devices segment accounted for the largest share of the market. It is also expected to register the highest CAGR during the forecast period. This can be attributed to clinical benefits offered (such as lack of barotrauma, less risk of neointimal hyperplasia, immediate change of bypass site, and availability of differently sized instruments to enable atherectomy in blood vessels) and ongoing technological advancements in the field of directional atherectomy.

Based on application, the peripheral vascular applications segment is estimated to have the largest share of the market in 2017.

Based on application, the market is categorized into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular applications segment accounted for the major share of the market owing to the significant availability of clinical evidence to support the therapeutic efficacy of atherectomy in PVD treatment and growing patient preference for minimally invasive surgical procedures.

Based on end user, the hospitals and surgical centers segment is expected to witness the highest growth during the forecast period.

Based on end user, the market is segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories & academic institutes. The hospitals and surgical centers segment is expected to register the highest CAGR during the forecast period. The large share of this segment is attributed to increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment, ongoing technological advancements in the field of minimally invasive or image-guided atherectomy procedures, rising incidence of chronic vascular diseases, and growing availability of healthcare reimbursements across major countries.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=133112140

North America is expected to dominate the atherectomy devices market in 2017.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the market in 2017, followed by Europe. Factors such as increasing availability of reimbursements for atherectomy devices, growing adoption of atherectomy devices among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials are driving the growth of the North American atherectomy devices market. However, Asia Pacific is expected to register the highest growth rate during the forecast period. This can be attributed to the increasing prevalence of target diseases, increasing healthcare expenditure, cost-effective (owing to the increase in localized manufacturing and strengthening of distribution networks of key product manufacturers), and rising awareness among surgeons related to the benefits offered by atherectomy systems (less revascularization rates, high efficacy, short procedural time).

Major players operating in the market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US). Other prominent players present in this market include Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Pain Management Devices Market by Device Type, Application & Mode of Purchase - 2021

The global pain management devices market is valued at an estimated USD 3.08 Billion in 2016 and is projected to grow at a CAGR of 8.5% during the forecast period of 2016 to 2021. A number of factors, such as the growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications, development of novel pain management device, established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries, and high proven efficacy of pain management device for the treatment of chronic pain are driving the growth of the global market. On the other hand, factors such as low awareness regarding the availability and use of pain management device, shortage of pain specialists, low number of pain clinics in several countries, existence of a gap in prevalence and treatment of chronic pain, and high procedural and purchase cost of pain management device are restraining the growth of the global market.

Article Link: http://www.marketsandmarkets.com/Market-Reports/pain-management-devices-market-91418163.html

The Asia-Pacific region has become an attractive destination for companies engaged in the manufacture of pain management device. The high growth opportunities in this regional segment can be attributed to a number of factors, including growing incidence of chronic diseases, improving healthcare infrastructure in the region, growing middle-class population and disposable income levels, and rising awareness about the safety and efficacy of pain management device. According to the U.S. Department of Commerce, Japan has one of the largest geriatric populations in the world, with at least 20% of its population aged 65 years and above. In 2012, 30 million people in Japan were aged above 65 years and this figure is projected to reach 39 million by 2030 and nearly 43 million by 2050. Driven by its high growth potential, leading companies operating in the market are focusing on expanding their presence in emerging APAC countries. In September 2013, DJO Global announced plans to launch 10 pain management device in India in a phased manner over the next five years. The company also planned to start its operations in India, starting with 40 distribution locations across the country.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=91418163

As of 2015, Medtronic plc (Ireland) held the leadership position in the global pain management devices market. Over the last three years, the company adopted new product launches, alliances, geographic expansion, and inorganic growth strategies such as acquisitions and agreements to maintain its leading position in the market. St. Jude Medical, Inc. (U.S.) and Boston Scientific Corporation (U.S.) are the other key players in this market.

Stakeholders

• Pain Management Device Manufacturing Companies
• Distributors and Suppliers
• Government Bodies
• Research Institutions and Universities
• Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the pain management devices market into the following segments and subsegments:

Global Pain Management Devices Market, by Type

• Neuromodulation Devices
  • Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • Spinal Cord Stimulation (SCS) Devices
• Ablation Devices
  • Radiofrequency Ablation Devices
  • Cryoablation Devices
• Analgesic Infusion Pumps
  • Intrathecal Infusion Pumps
  • External Infusion Pumps

Global Pain Management Devices Market, by Application

• Neuropathic Pain
• Cancer Pain
• Facial Pain and Migraine
• Musculoskeletal Pain
• Others (Pregnancy/Labor and Menstrual Pain, Sports Injuries, Post-operative Pain, and Trauma Pain)